Gilead Sciences, Inc. (GILD) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time GILD price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 58.3 Neutral
Market Cap $168.5B
Volume 5.6M
Fundamentals — 10-Q Q2 2026
Revenue $14.8B
Net Income $-8.5B
EPS $-6.82
Gross Margin 79.5%
Operating Margin -52.9%
Net Margin -57.4%
Debt / Equity 2.2x
P/E Ratio -19.9x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| O'day Daniel Patrick | Chairman & CEO | Sell | 15,000 | $130.31 | $2.0M | 2026 Aug 3 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $129.93 | $389,777 | 2026 Jul 15 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3,000 | $129.92 | $389,758 | 2026 Jul 15 |
| O'day Daniel Patrick | Chairman & CEO | Sell | 15,000 | $126.29 | $1.9M | 2026 Jul 1 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3,000 | $123.92 | $371,762 | 2026 Jun 15 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $125.40 | $376,200 | 2026 Jun 15 |
| O'day Daniel Patrick | Chairman & CEO | Sell | 15,000 | $131.46 | $2.0M | 2026 Jun 1 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $132.27 | $396,810 | 2026 May 15 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 28,000 | $131.29 | $3.7M | 2026 May 15 |
| O'day Daniel Patrick | Chairman & CEO | Sell | 10,000 | $129.16 | $1.3M | 2026 Apr 28 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $140.96 | $422,880 | 2026 Apr 15 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3,000 | $140.96 | $422,880 | 2026 Apr 15 |
| O'day Daniel Patrick | Chairman & CEO | Sell | 10,000 | $136.82 | $1.4M | 2026 Mar 27 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | 3,000 | $144.23 | $432,690 | 2026 Mar 16 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $144.23 | $432,690 | 2026 Mar 16 |
| O'Day Daniel Patrick | Chairman & CEO | Sell | 10,000 | $144.79 | $1.4M | 2026 Feb 27 |
| O'Day Daniel Patrick | Chairman & CEO | Sell | 10,000 | $124.83 | $1.2M | 2025 Dec 29 |
| Mercier Johanna | Chief Commercial Officer | Sell | 3,000 | $122.00 | $366,000 | 2025 Dec 15 |
| Dickinson Andrew D | Chief Financial Officer | Sell | 3,000 | $122.00 | $366,000 | 2025 Dec 15 |
| Bluestone Jeffrey | Director | Sell | 5,000 | $125.08 | $625,400 | 2025 Nov 28 |
Take GILD further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put GILD in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Gilead Sciences, Inc. next reports.
Set alerts on GILD
Get notified when Gilead Sciences, Inc. hits your price targets or technical conditions are met.
Get Started Free